Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis.

RMD open - 18 Feb 2026

Mertz Philippe, Elhani Inès, Koné-Paut Isabelle, Dan Diana, Roque Sandrine, Theodoropoulou Katerina, Pachlopnick Schmid Jana, Bader-Menier Brigitte, Belot Alexandre, Dumaine Cécile, Kevorkian-Verguet Charlotte, Cavelot Sébastien, Georgin-Lavialle Sophie, Hentgen Véronique

Abstract excerpt

INTRODUCTION: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease. Colchicine is the first-line treatment, yet 5-10% of patients are resistant, increasing the risk of complications like amyloidosis. In 2023, Batu et al proposed the Turkish Paediatric Autoinflammatory Diseases (TURPAID) score to predict colchicine resistance in paediatric FMF at diagnosis. Its utility in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Colchicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Familial Mediterranean Fever

Share to ROC Curve

Share to Turkey

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 41708156
DOI: 10.1136/rmdopen-2025-006409
PMCID: PMC12918656

Genes

MEFV

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis.PMID 41708156Read ↗

Clinical, genetic, and therapeutic differences in pediatric versus adult colchicine-resistant FMF patients.Semantic proximity Read ↗

Machine-learning algorithms for predicting colchicine resistance in Familial Mediterranean Fever.Semantic proximity Read ↗

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.Semantic proximity Read ↗

Preliminary Evaluation for the Development of a Scoring System to Predict Homozygous M694V Genotype in Familial Mediterranean Fever Patients: A Single-Center Study.Semantic proximity Read ↗

Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).Semantic proximity Read ↗

Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?Semantic proximity Read ↗

Subclinical inflammation in pediatric familial Mediterranean fever: predictors and follow-up results of a retrospective single-center cohort study.Semantic proximity Read ↗

Early predictors of colchicine resistance in familial Mediterranean fever.Semantic proximity Read ↗

Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal.Semantic proximity Read ↗

Can colchicine response be predicted in familial Mediterranean fever patients?Semantic proximity Read ↗

Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever.Semantic proximity Read ↗

Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.